No longer ‘dead or just hi­ber­nat­ing,’ drug­mak­ers re­turn to heart med­i­cines

In 2015, now-FDA Com­mis­sion­er Robert Califf joined in­dus­try, aca­d­e­m­ic and reg­u­la­to­ry rep­re­sen­ta­tives in Wash­ing­ton to dis­cuss why more drugs weren’t in de­vel­op­ment for car­dio­vas­cu­lar dis­eases …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER